3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
16
Esophageal Neoplasms
5
Stomach Neoplasms
3
Neoplasms
3
Neoplasm Metastasis
3
HER2-positive Breast Cancer
3
Colorectal Neoplasms
3
Adenocarcinoma Of Esophagus
3
Triple Negative Breast Neoplasms
2
Solid Tumors
2
Rectal Neoplasms
2
Prostatic Neoplasms
2
Multiple Myeloma
2
Endometrial Neoplasms
2
Anatomic Stage I Breast Cancer AJCC v8
2
Adenocarcinoma
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Pathologic Complete Response
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasm, Residual
1
Meningeal Neoplasms
1
Meningeal Carcinomatosis
1
Melanoma
1
Malignant Solid Neoplasm
1
Lymphoma, Non-Hodgkin
1
Interventions
Specimen Handling
2
Magnetic Resonance Spectroscopy
2
Epirubicin
2
pembrolizumab
1
lenvatinib
1
anlotinib
1
amivantamab
1
Pemetrexed
1
Observation
1
Nivolumab
1
Ipilimumab
1
Glutamate Carboxypeptidase II
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Adenoid Cystic
×
Trastuzumab
×
30 days
×
Clear all
No trials found.